Waddell & Reed Financial’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-73,761
Closed -$11.4M 509
2019
Q1
$11.4M Buy
73,761
+824
+1% +$95.6K 0.03% 414
2018
Q4
$6.78M Buy
72,937
+11,488
+19% +$1.64M 0.02% 436
2018
Q3
$11.5M Buy
61,449
+12,440
+25% +$3.55M 0.03% 402
2018
Q2
$20.6M Buy
49,009
+27,530
+128% +$9.28M 0.05% 331
2018
Q1
$6.45M Buy
21,479
+1,718
+9% +$476K 0.01% 457
2017
Q4
$5.6M Buy
+19,761
New +$5.56M 0.01% 464

Other funds holding OPTN

Waddell & Reed Financial's OPTN Position: Q2 2019 in Review

Waddell & Reed Financial sold out of OptiNose (OPTN) in Q2 2019, closing a stake of 73,761 shares — an estimated $11.4M sold.

Waddell & Reed Financial first reported a position in OPTN in Q4 2017 and held it in 6 quarters. The position peaked at $20.6M in Q2 2018. 73 funds tracked by Wall St. Rank hold OPTN as of Q2 2019.

  • Waddell & Reed Financial reported no remaining OptiNose position as of Q2 2019 after selling out during the quarter.
  • Waddell & Reed Financial sold 73,761 OptiNose shares in Q2 2019, an estimated $11.4M.
  • Waddell & Reed Financial first reported a position in OptiNose in Q4 2017 and held it in 6 quarters.
  • Waddell & Reed Financial's OptiNose position peaked at $20.6M in Q2 2018.
  • 73 funds tracked by Wall St. Rank held OptiNose as of Q2 2019.

Based on Waddell & Reed Financial's 13F filing for Q2 2019, filed 14 Aug 2019.